157 related articles for article (PubMed ID: 19844741)
1. Localization of indoleamine 2,3-dioxygenase in human esophageal squamous cell carcinomas.
Liu J; Lu G; Tang F; Liu Y; Cui G
Virchows Arch; 2009 Nov; 455(5):441-8. PubMed ID: 19844741
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Associated Fibroblasts and Microvessels Contribute to the Expression of Immunosuppressive Factor Indoleamine 2, 3-Dioxygenase in Human Esophageal Cancers.
Cui G; Li C; Xu G; Sun Z; Zhu L; Li Z; Zheng W; Li J; Yuan A
Pathol Oncol Res; 2018 Apr; 24(2):269-275. PubMed ID: 28470572
[TBL] [Abstract][Full Text] [Related]
3. Myeloid CD11c+ S100+ dendritic cells express indoleamine 2,3-dioxygenase at the inflammatory border to invasive lower lip squamous cell carcinoma.
Kuales MA; Wenzel J; Schmid-Wendtner MH; Bieber T; von Bubnoff D
Histol Histopathol; 2011 Aug; 26(8):997-1006. PubMed ID: 21692032
[TBL] [Abstract][Full Text] [Related]
4. Involvement of indoleamine 2,3-dioxygenase in impairing tumor-infiltrating CD8 T-cell functions in esophageal squamous cell carcinoma.
Zhang G; Liu WL; Zhang L; Wang JY; Kuang MH; Liu P; Lin YH; Dai SQ; Du J
Clin Dev Immunol; 2011; 2011():384726. PubMed ID: 22013481
[TBL] [Abstract][Full Text] [Related]
5. [Study of indoleamine 2,3-dioxygenase expression in patients of esophageal squamous cell carcinoma].
Sakurai K; Enomoto K; Amano S; Kimura T; Sugito K; Kimizuka K; Ikeda T; Shibata M; Negishi N
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1780-2. PubMed ID: 15553713
[TBL] [Abstract][Full Text] [Related]
6. Low expression of Bin1, along with high expression of IDO in tumor tissue and draining lymph nodes, are predictors of poor prognosis for esophageal squamous cell cancer patients.
Jia Y; Wang H; Wang Y; Wang T; Wang M; Ma M; Duan Y; Meng X; Liu L
Int J Cancer; 2015 Sep; 137(5):1095-106. PubMed ID: 25683635
[TBL] [Abstract][Full Text] [Related]
7. Tumoral indoleamine 2,3-dioxygenase expression predicts poor outcome in laryngeal squamous cell carcinoma.
Ye J; Liu H; Hu Y; Li P; Zhang G; Li Y
Virchows Arch; 2013 Jan; 462(1):73-81. PubMed ID: 23179760
[TBL] [Abstract][Full Text] [Related]
8. Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma.
Loeser H; Kraemer M; Gebauer F; Bruns C; Schröder W; Zander T; Alakus H; Hoelscher A; Buettner R; Lohneis P; Quaas A
J Immunol Res; 2020; 2020():2862647. PubMed ID: 33029538
[TBL] [Abstract][Full Text] [Related]
9. Expression of programmed cell death protein 1 (PD-1) and indoleamine 2,3-dioxygenase (IDO) in the tumor microenvironment and in tumor-draining lymph nodes of breast cancer.
Ye Q; Wang C; Xian J; Zhang M; Cao Y; Cao Y
Hum Pathol; 2018 May; 75():81-90. PubMed ID: 29447919
[TBL] [Abstract][Full Text] [Related]
10. Indoleamine 2,3-dioxygenase (IDO) is frequently expressed in stromal cells of Hodgkin lymphoma and is associated with adverse clinical features: a retrospective cohort study.
Choe JY; Yun JY; Jeon YK; Kim SH; Park G; Huh JR; Oh S; Kim JE
BMC Cancer; 2014 May; 14():335. PubMed ID: 24886161
[TBL] [Abstract][Full Text] [Related]
11. Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy.
Inaba T; Ino K; Kajiyama H; Shibata K; Yamamoto E; Kondo S; Umezu T; Nawa A; Takikawa O; Kikkawa F
Gynecol Oncol; 2010 Jun; 117(3):423-8. PubMed ID: 20350764
[TBL] [Abstract][Full Text] [Related]
12. Indoleamine-2,3-Dioxygenase in Non-Small Cell Lung Cancer: A Targetable Mechanism of Immune Resistance Frequently Coexpressed With PD-L1.
Volaric A; Gentzler R; Hall R; Mehaffey JH; Stelow EB; Bullock TN; Martin LW; Mills AM
Am J Surg Pathol; 2018 Sep; 42(9):1216-1223. PubMed ID: 29901571
[TBL] [Abstract][Full Text] [Related]
13. Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma.
Yang C; Zhou Y; Zhang L; Jin C; Li M; Ye L
Int J Clin Exp Pathol; 2015; 8(2):1768-75. PubMed ID: 25973066
[TBL] [Abstract][Full Text] [Related]
14. Indoleamine 2, 3-dioxygenase and B7-H1 expressions as prognostic and follow-up markers in human pancreatic carcinoma.
Wang L; Ma Q; Li D; Mu S; Li Y; Wang Y; Shi P; Yu H; Gao C; Guo K; Zhang Z
Pathol Res Pract; 2018 Sep; 214(9):1309-1314. PubMed ID: 30029936
[TBL] [Abstract][Full Text] [Related]
15. Exosomes-carrying Epstein-Barr virus-encoded small RNA-1 induces indoleamine 2, 3-dioxygenase expression in tumor-infiltrating macrophages of oral squamous-cell carcinomas and suppresses T-cell activity by activating RIG-I/IL-6/TNF-α pathway.
Burassakarn A; Srisathaporn S; Pientong C; Wongjampa W; Vatanasapt P; Patarapadungkit N; Ekalaksananan T
Oral Oncol; 2021 Jun; 117():105279. PubMed ID: 33819809
[TBL] [Abstract][Full Text] [Related]
16. The expression and prognostic relevance of indoleamine 2,3-dioxygenase in tongue squamous cell carcinoma.
Seppälä M; Halme E; Tiilikainen L; Luukkainen A; Laranne J; Rautiainen M; Huhtala H; Paavonen T; Toppila-Salmi S
Acta Otolaryngol; 2016 Jul; 136(7):729-35. PubMed ID: 26982018
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of indoleamine 2,3-dioxygenase activity and expression in nasopharyngeal carcinoma.
Ben-Haj-Ayed A; Moussa A; Ghedira R; Gabbouj S; Miled S; Bouzid N; Tebra-Mrad S; Bouaouina N; Chouchane L; Zakhama A; Hassen E
Immunol Lett; 2016 Jan; 169():23-32. PubMed ID: 26608400
[TBL] [Abstract][Full Text] [Related]
18. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma.
Riesenberg R; Weiler C; Spring O; Eder M; Buchner A; Popp T; Castro M; Kammerer R; Takikawa O; Hatz RA; Stief CG; Hofstetter A; Zimmermann W
Clin Cancer Res; 2007 Dec; 13(23):6993-7002. PubMed ID: 18056175
[TBL] [Abstract][Full Text] [Related]
19. Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer.
Karanikas V; Zamanakou M; Kerenidi T; Dahabreh J; Hevas A; Nakou M; Gourgoulianis KI; Germenis AE
Cancer Biol Ther; 2007 Aug; 6(8):1258-62. PubMed ID: 17700060
[TBL] [Abstract][Full Text] [Related]
20. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]